✦ LIBER ✦

Nonalcoholic steatohepatitis associated with psoriasis vulgaris

✍ Scribed by Teruo Matsumoto; Norihisa Suzuki; Hiroshi Watanabe; Makoto Irie; Kaoru Iwata; Akira Anan; Hidetoshi Nakane; Makoto Yoshikane; Shinya Nishizawa; Tetsuro Sohda; Shotaro Sakisaka

Book ID: 106179598
Publisher: Springer Japan
Year: 2004
Tongue: English
Weight: 248 KB
Volume: 39
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-004-1451-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pediatric nonalcoholic steatohepatitis a

Pediatric nonalcoholic steatohepatitis associated with hypopituitarism

✍ Kenichirou Nakajima; Etsuko Hashimoto; Hiroyuki Kaneda; Katsutoshi Tokushige; Ke 📂 Article 📅 2005 🏛 Springer Japan 🌐 English ⚖ 339 KB

Smoking is associated with histological

Smoking is associated with histological severity in nonalcoholic steatohepatitis

✍ Emmanuel A. Tsochatzis; George V. Papatheodoridis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB 👁 1 views

Hepatocellular carcinoma with nonalcohol

Hepatocellular carcinoma with nonalcoholic steatohepatitis

✍ Sayaka Mori; Takahiro Yamasaki; Isao Sakaida; Taro Takami; Eiki Sakaguchi; Terua 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 534 KB

Epidermolysis bullosa acquisita associat

Epidermolysis bullosa acquisita associated with psoriasis vulgaris

✍ D. Hoshina; D. Sawamura; T. Nomura; S. Tanimura; M. Abe; T. Onozuka; K. Kodama; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 653 KB

Orlistat for overweight subjects with no

Orlistat for overweight subjects with nonalcoholic steatohepatitis

✍ Joanna K. Dowman; Deborah Stocken; Jeremy W. Tomlinson; Philip Newsome 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 1 views

We read with interest the article by Harrison et al. 1 on the use of Orlistat in overweight patients with nonalcoholic steatohepatitis (NASH). Their prospective randomized trial of 41 patients concluded that improvement in liver histology was not significantly different after 36 weeks of treatment w

Orlistat for overweight subjects with no

Orlistat for overweight subjects with nonalcoholic steatohepatitis

✍ Teoman Dogru; Cemal Nuri Ercin; Ilker Tasci; Serkan Tapan; Zeki Yesilova; Ahmet 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 1 views

We read with great interest the article by Harrison et al. reporting the effect of Orlistat, an inhibitor of fat absorption, on the metabolic abnormalities, histopathologic findings, and cytokine levels in subjects with nonalcoholic steatohepatitis (NASH). 1 They showed that when compared to control